Oropharma SA
Oropharma reported total assets of 352,437 € at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Jul 2026).
The score of Oropharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -22 % Total assets -45 %
Accounts of the company itself (not consolidated).
The full file covers 14 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Oropharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Jul 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
- Year ended 31 Dec 2023filed on 10 Jul 2024
- Year ended 31 Dec 2022filed on 12 Jul 2023
- Year ended 31 Dec 2021filed on 11 Jul 2022
Oropharma's financial analysis
- Solvency56.0%sector median: 47.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Oropharma
Oropharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0431.268.730
- VAT number
- BE0431268730
- Peppol
- Registered · 0208:0431268730 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 27 May 1987
- Registered office
- 9800 Deinze
- Latest accounts
- 2025 · filed on 14 Jul 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Oropharma (SA) has been based in Deinze since 1987, active in: manufacture of medicaments. For 2025, it reports a net profit of 19,264 € and equity of 197,410 €; its revenue is not published. Its solvency stands at 56.0%, above the median of its sector (47.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Oropharma
Companies in the same business, of comparable size and area, outside its group.
- L - Pharma Manufacture of pharmaceutical preparations Turnhout · balance sheet 10 €
- RTLC Manufacture of pharmaceutical preparations Brussels · balance sheet 107,167 €
- Wandji Pharma International Manufacture of pharmaceutical preparations Tournai · balance sheet 357,118 €
- AdipoPharma Belgique Manufacture of pharmaceutical preparations Charleroi · balance sheet 398,195 €
- Laboratoires Sopreli Manufacture of pharmaceutical preparations Anderlecht · balance sheet €1.10m
- Alchemich Farma Manufacture of pharmaceutical preparations Houthalen-Helchteren · balance sheet 258,120 €
- DJB Medical Wholesale of pharmaceutical and medical goods Merchtem · balance sheet 406,739 €
- Medipharm Worldwide Group Manufacture of basic pharmaceutical products Tienen · balance sheet 331,081 €
Frequently asked questions about Oropharma
What is the revenue of Oropharma?
Oropharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Oropharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0431268730 for Oropharma, if the company is VAT-registered. Its company number (CBE) is 0431.268.730.
Where is the registered office of Oropharma?
According to the CBE register, the registered office of Oropharma is in 9800 Deinze.
What is the equity of Oropharma?
At the close of the 2025 financial year, the equity of Oropharma amounts to 197,410 €, a solvency of 56.0% of total assets.
Who manages Oropharma?
The register lists 5 active mandates at Oropharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Oropharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →